On July 18, 2023, Harrow Health, Inc. entered a definitive agreement with B. Riley Securities, Inc. related to a public offering of shares of Harrow's common stock at $17.75 per share. Harrow agreed to sell 3,380,282 shares and provided the underwriters a 30-day option to buy additional 507,042 shares, which was fully exercised. The sale concluded on July 21, 2023, with Harrow's total gross proceeds amounting to $69.0 million.